Applications and performance of monoclonal antibodies to human tartrate resistant acid phosphatase

Journal of Immunological Methods

Volumn 372, Issue 1-2, 2011, Pages 162-170

  Pradella, Silvia D Potenziani ^a   Slone, Stephen P ^a   Wu, Yi Ying ^b   Chao, Tsu Yi ^c   Parthasarathy, Ranga N ^d,e   Yam, Lung T ^a,e   Janckila, Anthony J ^a,e  

^a University of Louisville School of Medicine   (United States)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dendritic cell; Immunoassay; Macrophage; Monoclonal antibodies; Osteoclast; Tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 14 G6; MONOCLONAL ANTIBODY 162; MONOCLONAL ANTIBODY 203; MONOCLONAL ANTIBODY 220; MONOCLONAL ANTIBODY 89; MONOCLONAL ANTIBODY B9 C5; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVITY; ENZYME INACTIVATION; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ACID PHOSPHATASE; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; BONE DISEASES; HUMANS; IMMUNOASSAY; ISOENZYMES; SENSITIVITY AND SPECIFICITY;

EID: 80052510527     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2011.07.010     Document Type: Article

References (49)

1. Alatalo S.L., Ivaska K.K., Wagnespack S.G., Econs M.J., Väänänen H.K., Halleen J.M. Osteoclast-derived tartrate-resistant acid phosphatase 5b in Albers-Schoenberg disease (Type II autosomal-dominant osteopetrosis). Clin. Chem. 2004, 50:883.
2. Briggs T.A., Rice G.I., Daly S., Urquhart J., Gornall H., Bader-Meunier B., Baskar K., Baskar S., Baudouin V., Beresford M.W., Black G.C., Dearman R.J., de Zegher F., Foster E.S., Francès C., Hayman A.R., Hilton E., Job-Deslandre C., Kulkarni M.L., Le Merrer M., Linglart A., Lovell S.C., Maurer K., Musset L., Navarro V., Picard C., Puel A., Rieux-Laucat F., Roifman C.M., Scholl-Bürgi S., Smith N., Szynkiewicz M., Wiedeman A., Wouters C., Zeef L.A., Casanova J.L., Elkon K.B., Janckila A., Lebon P., Crow Y.J. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and type I interferon expression signature. Nat Genet. 2011, 43:127.
3. Chamberlain P., Compston J., Cox T.M., Hayman A.R., Imrie R.C., Reynolds K., Holmes S.D. Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: Development of a specific immunoassay of the isoenzymes in serum. Clin. Chem. 1995, 41:1495.
4. Chao T.Y., Lee S.H., Chen M.M., Neustadt D.H., Chaudhry U.A., Yam L.T., Janckila A.J. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a. Clin. Chim. Acta 2005, 359:132.
5. Chao T.Y., Yu J.C., Ku C.H., Chen M.M., Lee S.H., Janckila A.J., Yam L.T. Tartrate-resistant acid phosphatase 5b is a useful marker for extensive bone metastasis in breast cancer patients. Clin. Cancer Res. 2005, 15:544.
6. Chao T.Y., Wu Y.Y., Janckila A.J. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum marker for cancer with bone metastasis. Clin. Chim. Acta 2010, 411:1553.
7. Cheung C.K., Panesar N.S., Haines C., Masarei J., Swaminathan R. Immunoassay of a tartate-resistant acid phsophaatase in serum. Clin. Chem. 1995, 41:679.
8. Clark S.A., Ambrose W.W., Anderson T.R., Terrell R.S., Toverud S.U. Ultrastructural localization of tartrate-resistant acid phosphatase in rat osteoclasts by histochemistry and immunohistochemistry. J. Bone Miner. Res. 1989, 4:399.
9. Echetebu Z.O., Cox T.M., Moss D.W. Antibodies to porcine uteroferrin used in measurement of human tartrate-resistant acid phosphatase. Clin. Chem. 1987, 33:1832.
10. Esfandiari E., Bailey M., Stokes C.R., Cox T.M., Evans M.J., Hayman A.R. TRACP influences Th1 pathways by affecting dendritic cell function. J. Bone Miner. Res. 2006, 21:1367.
11. Fagerlund K.M., Ylipahkala H., Tiitinen S.L., Janckila A.J., Hamilton S., Mäentausta O., Väänänen H.K., Halleen J.M. Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphatase. Arch. Biochem. Biophys. 2006, 449:1.
12. Halleen J.M., Hentunen T.A., Karp M., Käkönen S.M., Pettersson K., Väänänen H.K. Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay. J. Bone Miner. Res. 1998, 15:683.
13. Halleen J.M., Alatalo S.L., Suominen H., Cheng S., Janckila A.J., Väänänen H.K. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J. Bone Miner. Res. 2000, 15:1337.
14. Hayman A.R. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 2008, 41:218.
15. Hayman A.R., Jones S.J., Boyde A., Foster D., Colledge W.H., Carlton M.B., Evans M.J., Cox T.M. Mice lacking tartrate-resistant acid phosphatase (Acp5) have disrupted endochondral ossification and mild osteoporosis. Development 1996, 122:3151.
16. Hayman A.R., Bune A.J., Bradley J.R., Rashbass J., Cox T.M. Osteoclastic tartrate-resistant acid phosphatase (Acp5): its localization to dendritic cells and diverse murine tissues. J. Histochem. Cytochem. 2000, 48:219.
17. Hayman A.R., Bune A.J., Cox T.M. Widespread expression of tartrate-resistant acid phosphatase (Acp5) in the mouse embryo. J. Anat. 2000, 196:433.
18. Janckila A.J., Yam L.T. Biology and Clinical Significance of Tartrate-Resistant Acid Phosphatases: New Perspectives on an Old Enzyme. Calcif. Tissue Int. 2009, 85:465.
19. Janckila A.J., Cardwell E.M., Yam L.T., Li C.Y. Hairy Cell Identification by Immunohistochemistry of Tartrate-Resistant Acid Phosphatase. Blood 1995, 85:2839.
20. Janckila A.J., Walton S.P., Yam L.T. Species Specificity of Monoclonal Antibodies to Human Tartrate-Resistant Acid Phosphatase. Biochem. Histochem. 1998, 73:316.
21. Janckila A.J., Takahashi K., Sun S.Z., Yam L.T. Tartrate-resistant acid phosphatase isoform 5b as a serum marker for osteoclastic activity. Clin. Chem. 2001, 47:74.
22. Janckila A.J., Neustadt D.H., Nakasato Y.R., Halleen J.M., Hentunen T., Yam L.T. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clin. Chim. Acta 2002, 320:49.
23. Janckila A.J., Parthasarathy R.N., Parthasarathy L.K., Seelan R.S., Hsueh Y.C., Rissanen J., Alatalo S.L., Halleen J.M., Yam L.T. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocyte-derived cells. J. Leukoc. Biol. 2005, 77:209.
24. Janckila A.J., Slone S.P., Lear S.C., Martin A., Yam L.T. Tartrate-resistant acid phosphatase as an Immunohistochemical marker for inflammatory macrophages. Am. J. Clin. Pathol. 2007, 127:556.
25. Janckila A.J., Neustadt D.H., Yam L.T. Significance of serum TRACP in rheumatoid arthritis. J. Bone Miner. Res. 2008, 23:1287.
26. Janckila A.J., Lederer E.D., Price B.A., Yam L.T. Tartrate-resistant acid phosphatase isoform 5a as an inflammation marker in end-stage renal disease. Clin. Nephrol. 2009, 71:387.
27. Janckila A.J., Lin H.F., Wu Y.Y., Ku C.H., Yang S.P., Lin W.S., Lee S.H., Yam L.T., Chao T.Y. Serum tartrate-resistant acid phosphatase isoform 5a (TRACP5a) as a potential risk marker in cardiovascular disease. Clin. Chim. Acta 2011, 412:963.
28. Kraenzlin M.E., Lau K.H.W., Liang L., Freeman T.K., Singer F.R., Stepan J., Baylink D.J. Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase. J. Clin. Endocrinol. Metab. 1990, 71:442.
29. Lam K.W., Siemens S.T., Li C.Y., Yam L.T. Enzyme immunoassay for tartrate-resistant acid phosphatase. Clin. Chem. 1982, 28:467.
30. Lång P., Schultzberg M., Andersson G. Expression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system. J. Histochem. Cytochem. 2001, 49:379.
31. Lau K.H., Onishi T., Werdegal J.E., Singer F.R., Baylink D.J. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin. Chem. 1987, 33:458.
32. Lausch E., Janecke A., Bros M., Trojandt S., Alanay Y., De Laet C., Hübner C.A., Meinecke P., Nishimura G., Matsuo M., Hirano Y., Tenoutasse S., Kiss A., Rosa R.F., Unger S.L., Renella R., Bonafé L., Spranger J., Unger S., Zabel B., Superti-Furga A. Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat gen. 2011, 43:132.
33. Ljusberg J., Wang Y., Lång P., Norgård M., Dodds R., Hultenby K., Ek-Rylander B., Andersson G. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J. Biol. Chem. 2005, 280:28370.
34. Miyazaki S., Igarishi M., Nagata A., Tominaga Y., Onodera K., Komoda T. Development of immunoassays for type-5 tartrate-resistant acid phosphatase in human serum. Clin. Chim. Acta 2003, 329:109.
35. Moss D.W. Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclasts and other macrophages. Clin. Chim. Acta 1992, 209:131.
36. Nakasato Y.R., Janckila A.J., Halleen J.M., Väänänen H.K., Walton S.P., Yam L.T. Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase. Clin. Chem. 1999, 45:2150.
37. Ohashi T., Igarashi Y., Mochizuki Y., Miura T., Inaba N., Katayama K., Tomonaga T., Nomura F. Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b. Clin. Chim. Acta 2007, 376:205.
38. Radzun H.J., Kreipe H., Parwaresch M.R. Tartrate-resistant acid phosphatase as a differentiation marker for the human mononuclear phagocyte system. Hematol. Oncol. 1983, 1:321.
39. Reinholt F.P., Widholm S.M., Ek-Rylander B., Andersson G. Ultrastructural localization of a tartrate-resistant acid ATPase in bone. J. Bone Miner. Res. 1990, 5:1055.
40. Rissanen J.P., Suominen M.I., Peng Z., Halleen J.M. Secreted tartrate-resistant acid phosphatase 5b is a marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif. Tissue Int. 2008, 82:108.
41. Scarneccia L., Minisola S., Pacitti M.T., Carnevale V., Romagnoli E., Rosso R., Mazzuoli G.F. Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand. J. Clin. Lab. Invest. 1991, 51:517.
42. Shih K.C., Janckila A.J., Kwok C.F., et al. Effects of exercise on insulin sensitivity, inflammatory cytokines and serum tartrate-resistant acid phosphatase 5a in obese Chinese male adolescents. Metabolism 2009, 59:144.
43. Vääräniemi J., Halleen J.M., Kaarlonen K., Ylipahkala H., Alatalo S.L., Andersson G., Kaija H., Vihko P., Väänänen H.K. Intracellular machinery for matrix degradation in bone-resorbing osteoclasts. J. Bone Miner. Res. 2004, 19:1432.
44. Wu Y., Lee J.W., Uy L., Abosleem B., Gunn H., Ma M., DeSilva B. Tartrate-resistant acid phosphatase (TRACP 5b): A biomarker of bone resorption rate in support of drug development: Modification, validation and application of the BoneTRAP® kit assay. J. Pharm. Biomed. Anal. 2009, 49:1203.
45. Yam L.T. Clinical significance of the human acid phosphatases. Am. J. Med. 1974, 56:604.
46. Yam L.T., Li C.Y., Lam K.W. Tartrate-resistant acid phosphatase isoenzymes in the reticulum cells of leukemic reticuloendotheliosis. N. Engl. J. Med. 1971, 284:367.
47. Yaziji H., Janckila A.J., Lear S.C., Martin A.W., Yam L.T. Immunohistochemical detection of tartrate-resistant acid phosphatase in non-hematopoietic human tissues. Am. J. Clin. Pathol. 1995, 104:397.
48. Ylipahkala H., Fagerlund K.M., Janckila A.J., Houston B., Laurie D., Halleen J.M. Specificity and clinical performance of two commercial TRACP 5b assays. J. Clin. Lab. 2009, 55:223.
49. Zenger S., Ek-Rylander B., Andersson G. Biogenesis of tartrate -resistant acid phosphatase isoforms 5a and 5b in stably transfected MDA-MB-231 breast cancer epithelial cells. Biochim. Biophys. Acta 2010, 1803:598.